These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats. Fornal CA; Martin FJ; Metzler CW; Jacobs BL J Pharmacol Exp Ther; 1999 Oct; 291(1):229-38. PubMed ID: 10490909 [TBL] [Abstract][Full Text] [Related]
3. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635. Fornal CA; Martin FJ; Metzler CW; Jacobs BL J Pharmacol Exp Ther; 1999 Oct; 291(1):220-8. PubMed ID: 10490908 [TBL] [Abstract][Full Text] [Related]
4. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain. Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386 [TBL] [Abstract][Full Text] [Related]
5. 5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus. Sprouse J; Braselton J; Reynolds L Biol Psychiatry; 2000 Jun; 47(12):1050-5. PubMed ID: 10862804 [TBL] [Abstract][Full Text] [Related]
6. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice. Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992 [TBL] [Abstract][Full Text] [Related]
8. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine. Béïque JC; Blier P; de Montigny C; Debonnel G Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853 [TBL] [Abstract][Full Text] [Related]
9. Flattening plasma corticosterone levels increases the prevalence of serotonergic dorsal raphe neurons inhibitory responses to nicotine in adrenalectomised rats. Frías-Domínguez C; Garduño J; Hernández S; Drucker-Colin R; Mihailescu S Brain Res Bull; 2013 Sep; 98():10-22. PubMed ID: 23872451 [TBL] [Abstract][Full Text] [Related]
10. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine. Hertel P; Nomikos GG; Svensson TH Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809 [TBL] [Abstract][Full Text] [Related]
11. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo. Hjorth S; Pettersson G Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622 [TBL] [Abstract][Full Text] [Related]
12. 5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus. Matos FF; Korpinen C; Yocca FD Eur J Pharmacol; 1996 Dec; 317(1):49-54. PubMed ID: 8982718 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections. Taber MT; Kinney GG; Pieschl RL; Yocca FD; Gribkoff VK Synapse; 2000 Oct; 38(1):17-26. PubMed ID: 10941137 [TBL] [Abstract][Full Text] [Related]
14. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats. Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189 [TBL] [Abstract][Full Text] [Related]
15. Effects of co-administration of a monoamine oxidase inhibitor and a 5-HT1A receptor antagonist on 5-hydroxytryptamine cell firing and release. Sharp T; Gartside SE; Umbers V Eur J Pharmacol; 1997 Feb; 320(1):15-9. PubMed ID: 9049597 [TBL] [Abstract][Full Text] [Related]
16. Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Yan QS; Yan SE Eur J Pharmacol; 2001 Apr; 418(1-2):55-64. PubMed ID: 11334865 [TBL] [Abstract][Full Text] [Related]
17. Venlafaxine and its interaction with WAY 100635: effects on serotonergic unit activity and behavior in cats. Bjorvatn B; Fornal CA; Martín FJ; Metzler CW; Jacobs BL Eur J Pharmacol; 2000 Sep; 404(1-2):121-32. PubMed ID: 10980270 [TBL] [Abstract][Full Text] [Related]
18. N-methyl-d-aspartate receptors regulate 5-HT release in the raphe nuclei and frontal cortex of freely moving rats: differential role of 5-HT1A autoreceptors. Pallotta M; Segieth J; Whitton PS Brain Res; 1998 Feb; 783(2):173-8. PubMed ID: 9507110 [TBL] [Abstract][Full Text] [Related]
19. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat. Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182 [TBL] [Abstract][Full Text] [Related]
20. Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Romero L; Bel N; Artigas F; de Montigny C; Blier P Neuropsychopharmacology; 1996 Oct; 15(4):349-60. PubMed ID: 8887989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]